Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
SGLT2 Inhibitors in Type 1 Diabetes: The Metabolic Perspective.
Journal: Handbook of experimental pharmacology
Published: August 12, 2026
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks.
Journal: Diabetes care
Published: April 11, 2025
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.
Journal: Diabetes care
Published: March 14, 2025
Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial.
Journal: Diabetes care
Published: December 19, 2024
Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
Journal: Journal of Alzheimer's disease : JAD
Published: December 31, 2023
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: May 22, 2023
The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and Beyond.
Journal: Journal of the Indian Institute of Science
Published: December 18, 2022
Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia?
Journal: Diabetes & metabolic syndrome
Published: October 22, 2022
Last Updated: 09/26/2026